Rapport Therapeutics, Inc. Common Stock (RAPP) Earnings Per Share (EPS)
Rapport Therapeutics, Inc. Common Stock (RAPP) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2023-12-31 | -$23.10 |
| 2024-12-31 | -$3.78 |
| 2025-12-31 | -$2.86 |
How RAPP compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| VYGR | Voyager Therapeutics Inc. | -$2.04 |
| IONS | Ionis Pharmaceuticals Inc. | -$2.38 |
| QTRX | Quanterix Corporation | -$2.51 |
| VSTM | Verastem Inc. | -$3.02 |
| SNDX | Syndax Pharmaceuticals Inc. | -$3.29 |
These are five companies in the same sector as RAPP with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Rapport Therapeutics, Inc. Common Stock Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("RAPP")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RAPP | $47.42 | +0.00% | 0.24M |
| 3 | ||||
| 4 | ||||
| 5 |